| Annual Financials | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 30 | 60 | 62 | 83 | 108 | 112 |
| Expenses | 29 | 53 | 54 | 67 | 88 | 94 |
| EBITDA | 2 | 7 | 8 | 16 | 20 | 18 |
| Operating Profit % | 5 % | 11 % | 13 % | 19 % | 15 % | 16 % |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 1 | 6 | 7 | 14 | 19 | 18 |
| Tax | 0 | 2 | 2 | 4 | 5 | 4 |
| Net Profit | 1 | 4 | 5 | 10 | 14 | 15 |
| EPS in ₹ | 6.07 | 38.05 | 46.76 | 6.16 | 8.28 | 9.16 |
Quest Laboratories
Quest Laboratories
101.05
+1.30
(1.30%)
Market Cap
165.59 Cr
PE Ratio
-
Volume
22,800.00
Day High - Low
102.00 - 99.25
52W High-Low
152.60 - 82.00
Key Fundamentals
Market Cap
165.59 Cr
EPS
9.16
PE Ratio
-
PB Ratio
-
Book Value
59.08
EBITDA
18.24
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
16.58
Debt to Equity
0.32
Actual
Company News
View All News
Quest Laboratories Limited disclosed that promoters did not encumber shares in FY26. The declaration was filed under SEBI (SAST) Regulations.
Quest Labs FY26 net profit rises 10.7%
May 30, 2026
May 30, 2026Quest Laboratories Limited reported a net profit of ₹1,501.74 lakh for FY26, up from ₹1,356.64 lakh in the previous year. Revenue from operations increased to ₹11,182.18 lakh.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,807.70 | #1 4,33,727.78 | 37.40 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 51.01 | |
6,638.00 | 1,76,218.04 | 68.76 | 10,560.00 | 8.73 | 2,520 | 13.44 | 50.29 | |
4,571.20 | 1,54,710.18 | 72.33 | 13,886.20 | 20.34 | 2,138 | -26.91 | 61.51 | |
1,389.40 | 1,12,233.05 | 28.93 | 29,044.60 | 2.24 | 3,870 | -55.32 | 54.93 | |
1,104.70 | 1,11,158.67 | 21.71 | 26,719.70 | 13.65 | 5,242 | 7.82 | 71.11 | |
1,275.40 | 1,06,450.37 | 25.60 | 33,593.30 | -0.44 | 3,998 | -86.05 | 45.75 | |
2,293.30 | 1,04,813.72 | #1 19.41 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 53.15 | |
2,381.10 | 98,293.02 | 50.54 | 14,277.60 | 12.03 | 1,750 | 31.75 | 51.93 | |
1,472.80 | 85,540.46 | 24.28 | 33,384.70 | 3.21 | 3,376 | 1.99 | 56.54 | |
1,394.30 | 75,272.20 | 84.38 | 6,812.90 | #1 21.03 | 884 | 21.18 | 62.27 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
3.35 %
Net Income Growth
7.43 %
Cash Flow Change
-875.08 %
ROE
-52.91 %
ROCE
-53.80 %
EBITDA Margin (Avg.)
-14.66 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 18 | 35 | 47 | 61 | 122 |
| Fixed Assets | 6 | 7 | 10 | 10 | 12 |
| Current Assets | 12 | 27 | 34 | 50 | 107 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 7 | 52 |
| Other Assets | 13 | 27 | 37 | 44 | 58 |
| Total Equity & Liabilities | 18 | 35 | 47 | 61 | 122 |
| Current Liabilities | 11 | 23 | 29 | 30 | 37 |
| Non Current Liabilities | 2 | 2 | 3 | 2 | 3 |
| Total Equity | 6 | 10 | 15 | 29 | 82 |
| Reserve & Surplus | 5 | 9 | 14 | 17 | 65 |
| Share Capital | 1 | 1 | 1 | 12 | 16 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 1 | 0 | 0 | 0 |
| Investing Activities | -1 | -2 | -4 | -5 | -44 |
| Operating Activities | 1 | 4 | 4 | 3 | -23 |
| Financing Activities | 0 | -0 | 0 | 2 | 67 |
Share Holding
| % Holding | Mar 2024 | May 2024 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 90.36 % | 90.36 % | 66.21 % | 66.78 % | 66.78 % | 66.78 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.61 % | 0.61 % |
| DIIs | 0.00 % | 0.00 % | 0.07 % | 0.00 % | 1.37 % | 2.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 24.35 % | 25.50 % | 28.37 % | 26.98 % |
| Others | 9.64 % | 9.64 % | 9.37 % | 7.72 % | 2.87 % | 3.58 % |
| No of Share Holders | 20 | 23 | 1,001 | 1,084 | 1,017 | 911 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Sept 2024 |  Annual General Meeting | NA | 04 Sept 2024 | 126.50 | 126.80 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 100.50 | 106.50 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 101.45 | 100.00 |
| 24 Jul 2025 | Quarterly Result Announcement | NA | 24 Jul 2025 | 92.95 | 107.75 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 86.05 | 88.65 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 101.20 | 134.35 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 115.45 | 116.10 |
Technical Indicators
RSI(14)
Neutral 37.82
ATR(14)
Less Volatile 5.46
STOCH(9,6)
Oversold 10.16
STOCH RSI(14)
Oversold 5.23
MACD(12,26)
Bearish -0.80
ADX(14)
Weak Trend 16.89
UO(9)
Bearish 33.32
ROC(12)
Downtrend And Accelerating -13.60
WillR(14)
Oversold -91.52
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
